Brazilian journal of otorhinolaryngology · 2025
Evaluation of oncological outcomes in patients with oral cavity cancer treated in a low-volume hospital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bettioli Sara de Souza, Graciano Agnaldo José, Borga Ana Lavratti, Fischer Carlos Augusto
Аннотация
OBJECTIVE: To evaluate the results of OCC patients treated in low-volume regional hospitals.
METHODS: This is a retrospective longitudinal study conducted with patients diagnosed with OCC and operated on in a low-volume hospital between January 2003 and December 2018.
RESULTS: 174 patients with OCC were treated at the institution ‒ an average of 11 patients/year. The most common tumor location was the tongue (48.2%), followed by the lip (18.2%). Squamous cell carcinomas were the most frequent (94.7% of patients). Adjuvant radiotherapy and chemotherapy were performed in 46.7% and 31.9% of patients, respectively. Almost 21% of patients had some postoperative complication. Specific survival of 62.6% and global survival of 58.2% after 3-years were similar to the results reported in high-volume centers. Disease-free survival was 45.8% in the same period.
CONCLUSION: Low-volume hospitals qualified for oncological treatments can present outcomes similar to those of high-volume centers, and are thus a regional option for patients with OCC.
LEVEL OF EVIDENCE: Level III.
METHODS: This is a retrospective longitudinal study conducted with patients diagnosed with OCC and operated on in a low-volume hospital between January 2003 and December 2018.
RESULTS: 174 patients with OCC were treated at the institution ‒ an average of 11 patients/year. The most common tumor location was the tongue (48.2%), followed by the lip (18.2%). Squamous cell carcinomas were the most frequent (94.7% of patients). Adjuvant radiotherapy and chemotherapy were performed in 46.7% and 31.9% of patients, respectively. Almost 21% of patients had some postoperative complication. Specific survival of 62.6% and global survival of 58.2% after 3-years were similar to the results reported in high-volume centers. Disease-free survival was 45.8% in the same period.
CONCLUSION: Low-volume hospitals qualified for oncological treatments can present outcomes similar to those of high-volume centers, and are thus a regional option for patients with OCC.
LEVEL OF EVIDENCE: Level III.